The results of in vitro experiments preliminarily prove that circGUCY1A2 inhibits proliferation and promotes apoptosis of NSCLC cells through the miR-200c-3p/PTEN axis, but the tumorigenic effect of circGUCY1A2 in vivo is still unclear. This evidence concerns the gene PTEN and non-small cell lung carcinoma.